FDA expands access to pancreatic cancer drug helping patients like Ben Sasse
The Food and Drug Administration said it will allow some pancreatic cancer patients to receive access to a promising drug, even before it is officially approved for use. The medication, daraxonrasib, is a pill taken three times a day. The drug blocks a signal that causes cancer cells to grow non-stop. Drugmaker Revolution Medicine reported … Read more